TRGC1 and COVID-19: TCRα/β and TCRγ/δ cells were significantly lower at the beginning of hospitalization and on day 7 in the ICU COVID-19 patients (all p < 0.001), with much lower levels regarding TCRγ/δ cells (Figure S3H,I).